The QIAGEN® QIAstat-Dx® Respiratory SARS-CoV-2 Panel

The QIAGEN® QIAstat-Dx® Respiratory SARS-CoV-2 Panel is a syndromic panel with the ability to impact infection control, antimicrobial stewardship, and patient outcomes by significantly reducing time to diagnosis and clinical decision making.

This multiplex syndromic cartridge detects and differentiates between 22 respiratory targets from nasopharyngeal swabs (NPS) eluted in universal transport media (UTM). The QIAstat-Dx Respiratory SARS-CoV-2 Panel is intended for the detection and differentiation of nucleic acid from SARS-CoV-2 and the following organism types and subtypes: Adenovirus, Coronavirus 229E, Coronavirus HKU1, Coronavirus NL63, Coronavirus OC43, SARS-CoV-2, Human Metapneumovirus A+B, Influenza A, Influenza A H1, Influenza A H3, Influenza A H1N1/pdm09, Influenza B, Parainfluenza virus 1, Parainfluenza virus 2, Parainfluenza virus 3, Parainfluenza virus 4, Rhinovirus/Enterovirus, Respiratory Syncytial Virus A+B, Bordetella pertussis, Chlamydophila pneumoniae, and Mycoplasma pneumoniae.

– Detection of 22 respiratory targets in about an hour
– Intuitive workflow with less than one-minute hands-on time
– No precision pipetting required
– Wet and dry reagents are preloaded
– Room temperature stable
– 6 test cartridges and transfer pipettes included in each kit

Interested in this product?
Request a quote